The Digital Health Intersection
Digital health devices may help treat chronic pain and enable patients to do more self care. The use of devices for data collection generated lot of discussion among participants. Panelists for the event were Erica Jackson, Moderator (K&L Gates), Adam Roth (Galvani Bioelectronics), Mircea Despa (BD Technologies), and Don Turner, Digital Health Impact & Transformation (DHIT).
Thanks to EFL Associates, Marsh & McLennan Agency and PwC for sponsoring the event.
Life Science Caucus Tours NC Research Campus
The Legislative Life Science Caucus members heard about nutrition and physiology research under way at the North Carolina Research Campus, which is celebrating its 10th anniversary. Presenters from Appalachian State University, told lawmakers the “Collaborative Approach to Human Performance Research” that it is undertaking with support from North Carolina State University’s “Plants for Human Health” initiative and Dole Food Company.
While touring the Research Campus’ facilities, lawmakers also heard from representatives the UNC-CH Nutrition Research Institute, NCCU Nutrition Research Program, the David H. Murdoch Research Institute, the NC State Food Processing and Innovation Center and a private company at the Campus, Endeve Laboratories.
During a luncheon, Life Science Co-Chair Senator Tamara Barringer (R-Wake) said the Caucus is visiting a variety of life science sites to find about “the wonderful things happening in life sciences across the State.” Co-Chair Representative Susan Martin (R-Wilson) added, “North Carolina is a leader in this industry, and we want to stay there so we will be emphasizing that in making policy and funding decisions.”
Biomanufacturing in North Carolina topic for April edition of Business North Carolina
NCBIO President Sam Taylor was moderator of a discussion roundtable about biomanufacturing in North Carolina. Participating in the discussion were Sergi Roura, President, Facilities North America, Grifols Shared Services, NA; Ted Lithgow, COO, Humacyte; Christine Vannais, Senior Director of Manufacturing, FUJIFILM Diosynth; Brandon Berga, AVP Plant Management, Merck; Bob Keynon, VP of North American Manufacturing, Biogen; Rep. Nelson Dollar, (R-Wake); Sam Taylor, President, NCBIO; Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer; Bill Bullock, Senior Vice President, NC Biotechnology Center.
NCBIO Participates in CED Life Science Conference and AdvaMed Fly-In
Amber Niebauer and Shaba Jones welcomed conference participants to the NCBIO booth the annual Life Science Conference. NCBIO was a co-host for the event.
Director of Communications Brenda Summers was at the AdvaMed Fly-In thanking members of the North Carolina Congressional delegation for supporting suspension of the medical device tax and asking for support of the "Ensuring Patient Access to Critical Breakthrough Products Act of 2018."
NCBIO Welcomes New Members
Eight new members were approved for membership in NCBIO at the Board meeting February 27th. They are Boston Analytical, Eva Garland Consulting, Falcon Therapeutics Inc, Gusto Global, LLC, LaunchBio, Inc., MedNet Solutions, Premex Inc., and Zymeron Corporation.
NCBIO with Legislative Life Science Caucus in Tour at Winston-Salem
Members of the Legislative Life Science Caucus toured Cook Medical and the Wake Forest University Innovation Quarter to find out more about the development of medical devices and innovation activities. The legislative group has been traveling to different areas of North Carolina to get a first-hand look at the state’s life science industry.
NCBIO Life Science Forum on Privacy and Data Security
NCBIO thanks Sean Blake of BioCryst for moderating discussion on privacy and data security with panelists: Brandon Champion, Syneos Health; Ted Medthun, FufjilmDiosynth; and Paulette Mara and Adrienne Ehrhardt, Michael Best & Friedrich LLP. Thanks to Donnelley Financial Solutions and Michael Best & Friedrich LLP for sponsoring the Lives Science Forum for members.
The panel members reviewed privacy and security laws, made suggestions on steps companies can take to strengthen security and encouraged them to focus on the most important areas to protect.
Local researchers, patient advocates, community leaders and experts from the state’s biopharmaceutical industry gathered for a public policy forum to discuss medical breakthroughs and biotechnology research. The panel discussion focused on medical innovation, particularly through the lens of HIV/AIDS research, advances in clinical trials and the ways in which North Carolin
a is a national leader for biotech research.
Panelists in picture, Michael Montello, IQVIA: Dr. Brian Johns, GSK, Alicia Diggs, NC AIDS Action Network; Doug Edgeton, NC Biotechnology Center; and Sam Taylor, NCBIO.
New NCBIO Officers and Board
Tom Staab, Senior Vice President and CFO of BioCryst, was re-elected and will serve an additional term as Chairman of NCBIO. NCBIO has also elected the Executive Committee for 2017-18 and elected new Board members. More
NCBIO Annual Meeting
NCBIO members had a full program of activities at the Annual Meeting. Leadership and Transitions was the topic of the opening presentation by Jeff George, formerly with the Novartis Group. David Hollinrake of Syngenta Seeds talked about the new era of innovation in agriculture, and Morten Nielsen discussed Novo Nordisk's decision to invest $2B in a new production facility in North Carolina.
JC Scott, AdvaMed; Allison Giles, Cook Medical Group; and Gavin Lindberg, Grifols talked with members about federal actions on health care, tax reform, repeal of medical device tax and other issues. Spotlight on Markets was the topic of a panel with Christy Shaffer (Moderator), Hatteras Ventures; Jim Douglas and Neil Riley, Piper Jaffray; and Todd Schwarzinger, Silicon Valley Bank.
Thanks to our sponsors for the Annual Meeting: Platinum: Bioventus, Cook Medical, Novo Nordisk and VWR; Gold: Bayer, BioNetwork, Fujifilm Diosynth, Grifols, Merz and The Conafay Group; Silver: AdvaMed, ALT, BIO, Kymanox, Office Depot, Patheon, UCB Biosciences, UniFirst/UniClean and UPS; and Bronze: BD, Business Wire, EY, G1 Therapeutics, Nikon, Novartis, Novozymes, PhRMA, PPD, and Royal Hill Consulting
"Company Development: Managing Risk and Brand" was the topic of discussion at the NCBIO Annual Meeting Dinner. NCBIO President Sam Taylor moderated a panel with Kristen Kraeger and Jim Walters of Aon Risk Solutions; Ford Worthy, Pappas Ventures; Michelle Douglas, Ketchum; and Steve Peterson, Trans Discovery.
Life Science Caucus
Members of the Legislative Life Science Caucus Members got a look at the NCBioImpact education programs September 22. Staring at the BTEC building at NC State University, lawmakers toured the BTEC labs and the NC Community College BioNetwork aseptic suite, which is being updated. They also visited the BRITE program at North Carolina Central University. “The institutions did a great job of educating lawmakers about the needs and also outlined the success of the programs in providing graduates and training for incumbent workers,” stated NCBIO President Sam Taylor. “We will be providing tours in other parts of the State so lawmakers can see the diversity of the industry in North Carolina.”
“Business Transformation: Approaches + Lessons Learned,” was the topic at the September NCBIO Biotech Manufacturers Forum (BMF) meeting. John Cassimatis of TayganPoint Consulting Group told participants that the drivers for business transformation are leadership changes, mergers and acquisitions, new regulation and compliance changes, health of pipeline and lifecycles, and technology.
House Senior Appropriations Chairman, Rep. Nelson Dollar (R-Wake), and Life Science Co-Chairs, Rep. Susan Martin (R-Pitt, Wilson), Rep. Ed Hanes (D-Forsyth) and Sen. Angela Bryant (D-Halifax, Nash, Vance, Warren and Wilson) talked with NCBIO Members during the annual Legislative Forum.
Rep. Dollar encouraged members to become advocates for SBIR matching grant funds, which were not included in the 2017-18 budget. He encouraged them to tell success stories about companies that had benefited from the funds. Rep. Martin talked about the importance of collaboration between industry and legislators. Rep. Hanes discussed the importance of working with researchers at the various universities in the state to drive innovation. Sen. Bryant asked members to develop graphics and information demonstrating the range of life science companies and the locations across North Carolina.
North Carolina has a long commitment to growing our state’s life science industry and that is indicated in reports by PhRMA highlighting North Carolina as a leader in "in Biotechnology Innovation and Education Amid Growing Global Competition."
Life Science programs received support from the North Carolina General Assembly. Click here for more information.